Enzalutamide approved for patients wi... - Advanced Prostate...

Advanced Prostate Cancer

21,044 members26,244 posts

Enzalutamide approved for patients with high risk of metastasis

Maxone73 profile image
27 Replies

onclive.com/view/fda-approv...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
27 Replies
PCaWarrior profile image
PCaWarrior

Clinical trial: Phase III trial of an adaptive therapy with excellent results. AUA 2023: EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-Risk Biochemically Recurrent Prostate Cancer

urotoday.com/conference-hig...

KocoPr profile image
KocoPr

Excellent bit I would like to see how darolutamide/Orgovyx with same criteria

MoonRocket profile image
MoonRocket

I just added Xtandi to my treatment due to this trial. Starting out with 80mgs a day...will move to 160 at my next appointment. Hoping to get to < .2 and then off treatment until 2.0. Another PSMA scan between 1 and 2 to find the bastards..last PSMA scan found zilch.

in reply to MoonRocket

I discussed this with my MO just days ago.

The trial was meant for initial use of Xtandi for nonmetastatic castration-sensitive prostate cancer.

If you're metastatic, you start with Zytiga, then got to Xtandi when becoming castration-resistant.

MoonRocket profile image
MoonRocket in reply to

Do you not think my MO and I know this?

And what do you infer from negative PSMA scans? That I'm metastatic?

in reply to MoonRocket

Your bio shows you as 3TbN1MO. N1 is metastatic, albeit near, but still metastatic.

I am N1 now too, hence my MO saying I was metastatic, even N1 is considered metastatic, and do not fit in that trial.

MoonRocket profile image
MoonRocket in reply to

You're wrong, N1 is not metastatic and all of my clinical notes per my RO, MO and consulting MO indicate that I am non-metastatic. N1 is regional prostate cancer which is classified as non-metastatic.

I've been at this a bit longer than you...I know my status.

in reply to MoonRocket

Please calm down. Its not a pissing contest, but a friendly debate.

As far as my MO and RO one lymph node is metastatic, N meaning NEAR metastatic (oligometastatic ). For the purpose of the Xtandi FDA approval mentioned above, N1 is metastatic in their eyes. It'smeant for confined to the prostate.

So let me ask you , why Xtandi, and not returning to Zytiga?

MoonRocket profile image
MoonRocket in reply to

I'm calm...N does not stand Near...it stands for Nodes, specifically those in the pelvic region.Metastasis (M) describes whether the cancer has spread to a different part of the body.

Because I'm considered BCR...as I indicated in my original post..hence I'm adding xtandi.

MoonRocket profile image
MoonRocket in reply to MoonRocket

My consulting MO is the Director of Translational Research in Prostate Cancer at MSK

in reply to MoonRocket

Im BCR too. Went over 4 years after RP, with PSA undetectable.

At .4 my team (I dont drop names) decided to start with Zytiga, and WPRT with extended field lymph nodes. Saving the Xtandi in case I become resistant.

Im PSMA clear in one year, and <0.02 PSA but I'll have Xtandi, in case of another BCR due to resistance. Or maybe Its cured. Going to stay on Zytiga one more year.

MoonRocket profile image
MoonRocket in reply to

Technically, you need to exceed 0.2 to be considered BCR after RP. Why would you restart ADT + zytiga at .04? What clinical studies are you and "your team" following that indicates ADT + zytiga with WPRT at 0.04?

I would also add, xtandi after zytiga is not a guarantee. Many get zero time on xtandi or so few months it doesn't justify the saving.

in reply to MoonRocket

Typo 0.4

I didn't restart. No ADT after RP, I was N0M0 at the time

My bio has the right numbers

MoonRocket profile image
MoonRocket in reply to

Reading your bio you are intermediate risk...so you could possibly be cured...I'm Gleason 9 ( 4+5) with a somatic ATM mutation, I'm high risk and am looking into all avenues of treatments...which why I have the name dropping consulting MO... he's an expert in HRR mutations and is actively conducting clinical trials with PARP and ATR inhibitors.

in reply to MoonRocket

I stated with RP in 2018!! Ive been at this longer!!😜

RJAMSG profile image
RJAMSG in reply to

How long were you “<“ after the RP?

in reply to RJAMSG

First PSA test at 90 days.

RJAMSG profile image
RJAMSG in reply to

So after the 90 days the psa remained at very low levels “.0 something” but never had the < again

in reply to RJAMSG

Undetectable, was <0.1 for 4 years. Starting with the first PSA test at 90 days post op. Then every 3 months for a year, then yearly. 0.2 appeared at 51 months post op.

PSA tests were not ultra sensitive, as any salvage treatment would not be considered until 0.2 or greater. Treatment was started when reached 0.4

MateoBeach profile image
MateoBeach in reply to MoonRocket

Good plan, MoonRocket

Plaxsis profile image
Plaxsis

Ok, end of round 5. Go to your corners.

Maxone73 profile image
Maxone73 in reply to Plaxsis

😂😂

London441 profile image
London441

Indeed. What seemed like the back and forth of an argument between 2 guys with the same pathology was an illusion! They can kiss and make up now.

MoonRocket profile image
MoonRocket in reply to London441

Jack Lalanne has appeared.

London441 profile image
London441 in reply to MoonRocket

I've been called worse😀

MoonRocket profile image
MoonRocket in reply to London441

I was hoping for one of your fitness stories..oh well..

j-o-h-n profile image
j-o-h-n

I call my sugar Xtandi....................... (enzalutamide)...

Good Luck, Good Health and Good Humor.

j-o-h-n Monday 11/20/2023 6:12 PM EST

You may also like...

High risk vs. aggressive cancer

I understand the definition of high-risk prostate cancer (Gleason, PSA and/or spread), but that...

Benefit of statin and metformin in the treatment of high risk CRPC

Correct Therapy for High Risk PCa (Gleason 9)

help - prostate cancer with bone metastasis in bones - patient 70 years old - PERU

Enzalutamide and Pluvicto

start taking enzalutamide after the scan but before treatment begins? Or, C) Enzalutamide doesn’t...